You are on page 1of 24

Cervical Cancer Test Market & Patients - Pap Smear,

HPV DNA, VIA Test & Patients Worldwide


Renub Research
www.renub.com
Published: April, 2014
Copyright 2014 Renub Research All Rights Reserved
Cervical Cancer Test Market Overview

Cervical cancer is one of the deadliest cancers among woman all over the world. However in
the past few decades, mortality from cervical cancer has significantly decreased in
developed countries due to widely use of Pap smear test. HPV DNA and VIA test are other
popular tests used across world. VIA test is most adoptable test in developing countries as it
is cheaper in comparison to Pap smear test and HPV DNA test.

Cervical cancer test market is dominated by United States in 2013. Germany and United
Kingdom are other top two leaders in this market place. In Asian region, China and India are
top two countries having largest cervical cancer test population. Few countries have also
shown a decline in cervical cancer test market. However VIA test market accounts for
largest share in cervical cancer test market in the case of developing countries like India
and China.


A high prevalence of HPV-infected patients across the globe, rising incidences of teenage
sexual cases, a rising number of organized cervical cancer programs initiated by
governments and NGOs and introduction of low cost VIA test are some of the major growth
drivers for the cervical cancer test market. However, lack of insufficient healthcare
infrastructure and lack of cervical cancer screening awareness are the major hinder for
cervical testing market.

Renub Research report titled "Cervical Cancer Test Market & Patients - Pap Smear, HPV
DNA, VIA Test & Patients Worldwide provides a comprehensive analysis of the current
state of this market and likely future evolution over the next 5 years. This 232 page report
with 240 Figures and 14 Table provides a complete analysis of top 20 Countries Cervical
Cancer Test Market & Population. All the 20 countries in the report have been studied
from 3 viewpoints.

1. Cervical cancer Test Population (2007-2020)
Pap smear test population (2007-2020)
HPV DNA test population (2007-2020)
VIA test Population (2007-2020)

2. Cervical Cancer Mortality Population (2001-2011)

3. Cervical Cancer Test Market (2007-2020)
Pap smear test market (2007-2020)
HPV DNA test market (2007-2020)
VIA test market (2007-2020)


All the 20 Countries studied in the report are as follows

1. United Kingdom
2. France
3. Germany
4. Italy
5. Spain
6. Sweden
7. Switzerland
8. Norway
9. Netherlands
10. United States
11. Canada
12. Japan
13. Korea
14. Singapore
15. Malaysia
16. Australia
17. India
18. China
19. Thailand
20. Indonesia
Renub Research Page 4 of 24

Data Sources

This report is built using data and information sourced from proprietary databases, primary and
secondary research and in-house analysis by Renub Research team of industry experts. Primary
sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-
printable sources like search engines, News websites, Government Websites, Trade Journals,
White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books,
Industry Portals, Industry Associations and access to more than 500 paid databases.


Renub Research Page 5 of 24
About Us

R Re en nu ub b R Re es se ea ar rc ch h is a leading Market Research and Information Analysis Company with
centers at Noida India and Roswell USA. We have long-term experience especially in
international Business-to-Business Researches, Surveys, Business and Consulting. Throughout
the years we have acquired expertise in most market sectors, including Information Technology
(IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking,
Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer
Goods, Logistics, Governmental, Social, and Others.

Our core team is comprised of an experienced people holding graduate, post graduate and
Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information
Technology, Environmental Science and many more. Our research help make the business
decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We
support many blue chip companies by providing them findings and perspectives across a wide
range of markets. Our research reports offer a blend of information insight, analysis and
forecasting that is essential in todays ultra-competitive markets.


For more information on us or to view any of our sample work you can mail
us at info@renub.com

Renub Research Page 6 of 24





Published
By
R Re en nu ub b R Re es se ea ar rc ch h
1
st
Floor,
C-86, Sector10
Noida 201301
Phone: +91-120-421-9822, 254-5750 (India)
+1-678-302-0700 (USA)
Fax : +91-120-424-9780
Email: info@renub.com
www.renub.com






Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA Test & Patients
Worldwide
Renub Research, 2014
Edition 1.0
All rights reserved. This publication is protected
by copyright. No part of it may be reproduced, stored
in a retrieval system or transmitted, in any form or by
any means, electronic mechanical, photocopying,
recording or otherwise without the prior written
permission of the publishers

Renub Research Page 7 of 24
Table of Contents

1. Executive Summary
2. Worldwide Cervical Cancer Test (Screening) Population & Forecast
3. Worldwide Cervical Cancer Test (Screening) Market & Forecast
3.1 Worldwide Cervical Cancer Pap Smear Test (Screening) Market & Forecast
3.2 Worldwide Cervical Cancer HPV DNA Test (Screening) Market & Forecast
3.3 Worldwide - Cervical Cancer Visual Inspection with Acetic Acid (VIA) Test (Screening) Market &
Forecast
4. Worldwide Cervical Cancer Test (Screening) Population Share, Market Share & Forecast
4.1 Worldwide Cervical Cancer Test (Screening) Population Share & Forecast
4.2 Worldwide Cervical Cancer Test (Screening) Market Share & Forecast
4.3 Worldwide Cervical Cancer Pap Smear Test (Screening) Market Share & Forecast
4.4 Worldwide Cervical Cancer HPV DNA Test (Screening) Market Share & Forecast
4.5 Worldwide Cervical Cancer VIA Test (Screening) Market Share & Forecast
5. United Kingdom Cervical Cancer Test Analysis
5.1 United Kingdom Cervical Cancer Test (Screening) Population
5.1.1 United Kingdom Cervical Cancer Pap Smear Test Population & Forecast
5.1.2 United Kingdom Cervical Cancer HPV DNA Test Population & Forecast
5.2 United Kingdom Cervical Cancer Mortality
5.3 United Kingdom Cervical Cancer Test (Screening) Analysis
5.3.1 United Kingdom Cervical Cancer Test Market & Forecast
5.3.2 United Kingdom Pap Smear Test Market & Forecast
5.3.3 United Kingdom HPV DNA Test Market & Forecast
6. France Cervical Cancer Test Analysis
6.1 France Cervical Cancer Test (Screening) Population
6.1.1 France Cervical Cancer Pap Smear Test Population & Forecast
6.1.2 France Cervical Cancer HPV DNA Test Population & Forecast
6.2 France Cervical Cancer Mortality
6.3 France Cervical Cancer Test (Screening) Analysis
Renub Research Page 8 of 24
6.3.1 France Cervical Cancer Test Market & Forecast
6.3.2 France Pap Smear Test Market & Forecast
6.3.3 France HPV DNA Test Market & Forecast
7. Germany Cervical Cancer Test Analysis
7.1 Germany Cervical Cancer Test (Screening) Population
7.1.1 Germany Cervical Cancer Pap Smear Test Population & Forecast
7.1.2 Germany Cervical Cancer HPV DNA Test Population & Forecast
7.2 Germany Cervical Cancer Mortality
7.3 Germany Cervical Cancer Test (Screening) Market
7.3.1 Germany Cervical Cancer Test Market & Forecast
7.3.2 Germany Pap Smear Test Market & Forecast
7.3.3 Germany HPV DNA Test Market & Forecast
8. Italy Cervical Cancer Test Analysis
8.1 Italy Cervical Cancer Test (Screening) Population
8.1.1 Italy Cervical Cancer Pap Smear Test Population & Forecast
8.1.2 Italy Cervical Cancer HPV DNA Test Population & Forecast
8.2 Italy Cervical Cancer Mortality
8.3 Italy Cervical Cancer Test (Screening) Market
8.3.1 Italy Cervical Cancer Test Market & Forecast
8.3.2 Italy Pap Smear Test Market & Forecast
8.3.3 Italy HPV DNA Test Market & Forecast
9. Spain Cervical Cancer Test Analysis
9.1 Spain Cervical Cancer Test (Screening) Population
9.1.1 Spain Cervical Cancer Pap Smear Test Population & Forecast
9.1.2 Spain Cervical Cancer HPV DNA Test Population & Forecast
9.2 Spain Cervical Cancer Mortality
9.3 Spain Cervical Cancer Test (Screening) Market
9.3.1 Spain Cervical Cancer Test Market & Forecast
9.3.2 Spain Pap Smear Test Market & Forecast
9.3.3 Spain HPV DNA Test Market & Forecast
10. Sweden Cervical Cancer Test Analysis
10.1 Sweden Cervical Cancer Test (Screening) Population
10.1.1 Sweden Cervical Cancer Pap Smear Test Population & Forecast
Renub Research Page 9 of 24
10.1.2 Sweden Cervical Cancer HPV DNA Test Population & Forecast
10.2 Sweden Cervical Cancer Mortality
10.3 Sweden Cervical Cancer Test (Screening) Market
10.3.1 Sweden Cervical Cancer Test Market & Forecast
10.3.2 Sweden Pap Smear Test Market & Forecast
10.3.3 Sweden HPV DNA Test Market & Forecast
11. Switzerland Cervical Cancer Test Analysis
11.1 Switzerland Cervical Cancer Test (Screening) Population
11.1.1 Switzerland Cervical Cancer Pap Smear Test Population & Forecast
11.1.2 Switzerland Cervical Cancer HPV DNA Test Population & Forecast
11.2 Switzerland Cervical Cancer Mortality
11.3 Switzerland Cervical Cancer Test (Screening) Market
11.3.1 Switzerland Cervical Cancer Test Market & Forecast
11.3.2 Switzerland Pap smear Test Market & Forecast
11.3.3 Switzerland HPV DNA Test Market & Forecast
12. Norway Cervical Cancer Test Analysis
12.1 Norway Cervical Cancer Test (Screening) Population
12.1.1 Norway Cervical Cancer Pap Smear Test Population & Forecast
12.1.2 Norway Cervical Cancer HPV DNA Test Population & Forecast
12.2 Norway Cervical Cancer Mortality
12.3 Norway Cervical Cancer Test (Screening) Market
12.3.1 Norway Cervical Cancer Test Market & Forecast
12.3.2 Norway Pap Smear Test Market & Forecast
12.3.3 Norway HPV DNA Test Market & Forecast
13. Netherlands Cervical Cancer Test Analysis
13.1 Netherlands Cervical Cancer Test (Screening) Population
13.1.1 Netherlands Cervical Cancer Pap Smear Test Population & Forecast
13.1.2 Netherlands Cervical Cancer HPV DNA Test Population & Forecast
13.2 Netherlands Cervical Cancer Mortality
13.3 Netherlands Cervical Cancer Test (Screening) Market
13.3.1 Netherlands Cervical Cancer Test Market & Forecast
13.3.2 Netherlands Pap Smear Test Market & Forecast
13.3.3 Netherlands HPV DNA Test Market & Forecast
Renub Research Page 10 of 24
14. United States Cervical Cancer Test Analysis
14.1 United States Cervical Cancer Test (Screening) Population
14.1.1 United States Cervical Cancer Pap Smear Test Population & Forecast
14.1.2 United States Cervical Cancer HPV DNA Test Population & Forecast
14.2 United States Cervical Cancer Mortality
14.3 United States Cervical Cancer Test (Screening) Market
14.3.1 United States Cervical Cancer Test Market & Forecast
14.3.2 United States Pap smear Test Market & Forecast
14.3.3 United States HPV DNA Test Market & Forecast
15. Canada Cervical Cancer Test Analysis
15.1 Canada Cervical Cancer Test (Screening) Population
15.1.1 Canada Cervical Cancer Pap Smear Test Population & Forecast
15.1.2 Canada Cervical Cancer HPV DNA Test Population & Forecast
15.2 Canada Cervical Cancer Mortality
15.3 Canada Cervical Cancer Test (Screening) Market
15.3.1 Canada Cervical Cancer Test Market & Forecast
15.3.2 Canada Pap Smear Test Market & Forecast
15.3.3 Canada HPV DNA Test Market & Forecast
16. Japan Cervical Cancer Test Analysis
16.1 Japan Cervical Cancer Test (Screening) Population
16.1.1 Japan Cervical Cancer Pap Smear Test Population & Forecast
16.1.2 Japan Cervical Cancer HPV DNA Test Population & Forecast
16.2 Japan Cervical Cancer Mortality
16.3 Japan Cervical Cancer Test (Screening) Market
16.3.1 Japan Cervical Cancer Test Market & Forecast
16.3.2 Japan Pap Smear Test Market & Forecast
16.3.3 Japan HPV DNA Test Market & Forecast
17. South Korea Cervical Cancer Tests Analysis
17.1 South Korea - Cervical Cancer Test (Screening) Population
17.1.1 South Korea - Cervical Cancer Pap Smear Test Population & Forecast
17.1.2 Korea Cervical Cancer HPV DNA Test Population & Forecast
17.2 Korea Cervical Cancer Mortality
Renub Research Page 11 of 24
17.3 Korea Cervical Cancer Test (Screening) Market
17.3.1 Korea Cervical Cancer Test Market & Forecast
17.3.2 Korea Pap Smear Test Market & Forecast
17.3.3 Korea HPV DNA Test Market & Forecast
18. Singapore Cervical Cancer Tests Analysis
18.1 Singapore - Cervical Cancer Test (Screening) Population
18.1.1 Singapore - Cervical Cancer Pap Smear Test Population & Forecast
18.1.2 Singapore Cervical Cancer HPV DNA Test Population & Forecast
18.2 Singapore Cervical Cancer Test (Screening) Market
18.2.1 Singapore Cervical Cancer Test Market & Forecast
18.2.2 Singapore Pap Smear Test Market & Forecast
18.2.3 Singapore HPV DNA Test Market & Forecast
19. Malaysia Cervical Cancer Test Analysis
19.1 Malaysia - Cervical Cancer Test (Screening) Population
19.1.1 Malaysia Cervical Cancer Pap Smear Test Population & Forecast
19.1.2 Malaysia Cervical Cancer HPV DNA Test Population & Forecast
19.2 Malaysia Cervical Cancer Test (Screening) Market
19.2.1 Malaysia Cervical Cancer Test Market & Forecast
19.2.2 Malaysia Pap Smear Test Market & Forecast
19.2.3 Malaysia HPV DNA Test Market & Forecast
20. Australia Cervical Cancer Test Analysis
20.1 Australia - Cervical Cancer Test (Screening) Population
20.1.1 Australia Cervical Cancer Pap Smear Test Population & Forecast
20.1.2 Australia Cervical Cancer HPV DNA Test Population & Forecast
20.2 Australia Cervical Cancer Mortality
20.3 Australia Cervical Cancer Test (Screening) Market
20.3.1 Australia Cervical Cancer Test Market & Forecast
20.3.2 Australia Pap Smear Test Market & Forecast
20.3.3 Australia HPV DNA Test Market & Forecast
21. India Cervical Cancer Test Analysis
21.1 India - Cervical Cancer Test (Screening) Population
21.1.1 India Cervical Cancer Pap Smear Test Population & Forecast
21.1.2 India Cervical Cancer HPV DNA Test Population & Forecast
Renub Research Page 12 of 24
21.1.3 India Cervical Cancer VIA Test Population & Forecast
21.2 India Cervical Cancer Test (Screening) Market
21.2.1 India Cervical Cancer Test Market & Forecast
21.2.2 India Pap Smear Test Market & Forecast
21.2.3 India HPV DNA Test Market & Forecast
21.2.4 India VIA Test Market & Forecast
22. China Cervical Cancer Test Analysis
22.1 China - Cervical Cancer Test (Screening) Population
22.1.1 China Cervical Cancer Pap smear Test Population & Forecast
22.1.2 China Cervical Cancer HPV DNA Test Population & Forecast
22.1.3 China Cervical Cancer VIA Test Population & Forecast
22.2 China - Cervical Cancer Test (Screening) Market
22.2.1 China Cervical Cancer Test Market & Forecast
22.2.2 China Pap Smear Test Market & Forecast
22.2.3 China HPV DNA Test Market & Forecast
22.2.4 China VIA Test Market & Forecast
23. Thailand Cervical Cancer Test Analysis
23.1 Thailand - Cervical Cancer Test (Screening) Population
23.1.1 Thailand Cervical Cancer Pap Smear Test Population & Forecast
23.1.2 Thailand Cervical Cancer VIA Test Population & Forecast
23.2 Thailand Cervical Cancer Test (Screening) Market
23.2.1 Thailand Cervical Cancer Test Market & Forecast
23.2.2 Thailand Pap smear Test Market & Forecast
23.2.3 Thailand VIA Test Market & Forecast
24. Indonesia Cervical Cancer Test Analysis
24.1 Indonesia Cervical Cancer Test (Screening) Population
24.1.1 Indonesia Cervical Cancer Pap Smear Test Population & Forecast
24.1.2 Indonesia Cervical Cancer HPV DNA Test Population & Forecast
24.1.3 Indonesia Cervical Cancer VIA Test Population & Forecast
24.1.4 Indonesia Cervical Cancer Both (Pap Smear & VIA) Test Population & Forecast
24.2 Indonesia Cervical Cancer Test (Screening) Market
24.2.1 Indonesia Cervical Cancer Test Market & Forecast
24.2.2 Indonesia Pap smear Test Market & Forecast
24.2.3 Indonesia HPV DNA Test Market & Forecast
Renub Research Page 13 of 24
24.2.4 Indonesia VIA Test Market & Forecast
24.2.5 Indonesia Cervical Cancer Both (Pap Smear & VIA) Test Market & Forecast
25. Cervical Cancer Test Market Growth Drivers
25.1 Point No. 1
25.2 Point No. 2
25.3 Point No. 3
26. Challenges in Cervical Cancer Test Market
26.1 Point No. 1
26.2 Point No. 2



Renub Research Page 14 of 24
List of Figures:

Figure 2-1: Worldwide Cervical Cancer Test Population (Million), 2005 2013
Figure 2-2: Worldwide Forecast for Cervical Cancer Test Population (Million), 2014 2020
Figure 3-1: Worldwide Cervical Cancer Test Market (Million US$), 2005 2013
Figure 3-2: Worldwide Forecast for Cervical Cancer Test Market (Million US$), 2014 2020
Figure 3-3: Worldwide Cervical Cancer Pap Smear Test Market (Million US$), 2005 2013
Figure 3-4: Worldwide Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2014 2020
Figure 3-5: Worldwide Cervical Cancer HPV DNA Test Market (Million US$), 2005 2013
Figure 3-6: Worldwide Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2014 2020
Figure 3-7: Worldwide Cervical Cancer VIA Test Market (Million US$), 2005 2013
Figure 3-8: Worldwide Forecast for Cervical Cancer VIA Test Market (Million US$), 2014 2020
Figure 5-1: United Kingdom Cervical Cancer Pap Smear Test Population (Thousand), 2005 2013
Figure 5-2: United Kingdom Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014
2020
Figure 5-3: United Kingdom Cervical Cancer HPV DNA Test Population (Thousand), 2005 2013
Figure 5-4: United Kingdom Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014
2020
Figure 5-5: United Kingdom Cervical Cancer Mortality (Number), 2001 2011
Figure 5-6: United Kingdom Cervical Cancer Test Market (Million US$), 2005 2013
Figure 5-7: United Kingdom Forecast for Cervical Cancer Test Market (Million US$), 2014 2020
Figure 5-8: United Kingdom Pap Smear Test Market (Million US$), 2005 2013
Figure 5-9: United Kingdom Forecast for Pap Smear Test Market (Million US$), 2014 2020
Figure 5-10: United Kingdom HPV DNA Test Market (Million US$), 2005 2013
Figure 5-11: United Kingdom Forecast for HPV DNA Test Market (Million US$), 2014 2020
Figure 6-1: France Cervical Cancer Pap Smear Test Population (Thousand), 2005 2013
Figure 6-2: France Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 2020
Figure 6-3: France Cervical Cancer HPV DNA Test Population (Thousand), 2005 2013
Figure 6-4: France Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 2020
Figure 6-5: France Cervical Cancer Mortality (Number), 2001 2011
Figure 6-6: France Cervical Cancer Test Market (Million US$), 2005 2013
Figure 6-7: France Forecast for Cervical Cancer Test Market (Million US$), 2014 2020
Figure 6-8: France Pap Smear Test Market (Million US$), 2005 2013
Figure 6-9: France Forecast for Pap Smear Test Market (Million US$), 2014 2020
Figure 6-10: France HPV DNA Test Market (Million US$), 2005 2013
Figure 6-11: France Forecast for HPV DNA Test Market (Million US$), 2014 2020
Figure 7-1: Germany Cervical Cancer Pap Smear Test Population (Thousand), 2005 2013
Renub Research Page 15 of 24
Figure 7-2: Germany Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 2020
Figure 7-3: Germany Cervical Cancer HPV DNA Test Population (Thousand), 2005 2013
Figure 7-4: Germany Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 2020
Figure 7-5: Germany Cervical Cancer Mortality (Number), 2001 2011
Figure 7-6: Germany Cervical Cancer Test Market (Million US$), 2005 2013
Figure 7-7: Germany Forecast for Cervical Cancer Test Market (Million US$), 2014 2020
Figure 7-8: Germany Pap Smear Test Market (Million US$), 2005 2013
Figure 7-9: Germany Forecast for Pap Smear Test Market (Million US$), 2014 2020
Figure 7-10: Germany HPV DNA Test Market (Million US$), 2005 2013
Figure 7-11: Germany Forecast for HPV DNA Test Market (Million US$), 2014 2020
Figure 8-1: Italy Cervical Cancer Pap Smear Test Population (Thousand), 2005 2013
Figure 8-2: Italy Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 2020
Figure 8-3: Italy Cervical Cancer HPV DNA Test Population (Thousand), 2005 2013
Figure 8-4: Italy Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 2020
Figure 8-5: Italy Cervical Cancer Mortality (Number), 2001 2011
Figure 8-6: Italy Cervical Cancer Test Market (Million US$), 2005 2013
Figure 8-7: Italy Forecast for Cervical Cancer Test Market (Million US$), 2014 2020
Figure 8-8: Italy Pap Smear Test Market (Million US$), 2005 2013
Figure 8-9: Italy Forecast for Pap Smear Test Market (Million US$), 2014 2020
Figure 8-10: Italy HPV DNA Test Market (Million US$), 2005 2013
Figure 8-11: Italy Forecast for HPV DNA Test Market (Million US$), 2014 2020
Figure 9-1: Spain Cervical Cancer Pap Smear Test Population (Thousand), 2005 2013
Figure 9-2: Spain Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 2020
Figure 9-3: Spain Cervical Cancer HPV DNA Test Population (Thousand), 2005 2013
Figure 9-4: Spain Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 2020
Figure 9-5: Spain Cervical Cancer Mortality (Number), 2001 2011
Figure 9-6: Spain Cervical Cancer Test Market (Million US$), 2005 2013
Figure 9-7: Spain Forecast for Cervical Cancer Test Market (Million US$), 2014 2020
Figure 9-8: Spain Pap Smear Test Market (Million US$), 2005 2013
Figure 9-9: Spain Forecast for Pap Smear Test Market (Million US$), 2014 2020
Figure 9-10: Spain HPV DNA Test Market (Million US$), 2005 2013
Figure 9-11: Spain Forecast for HPV DNA Test Market (Million US$), 2014 2020
Figure 10-1: Sweden Cervical Cancer Pap Smear Test Population (Thousand), 2005 2013
Figure 10-2: Sweden Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 2020
Figure 10-3: Sweden Cervical Cancer HPV DNA Test Population (Thousand), 2005 2013
Figure 10-4: Sweden Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 2020
Figure 10-5: Sweden Cervical Cancer Mortality (Number), 2001 2011
Renub Research Page 16 of 24
Figure 10-6: Sweden Cervical Cancer Test Market (Million US$), 2005 2013
Figure 10-7: Sweden Forecast for Cervical Cancer Test Market (Million US$), 2014 2020
Figure 10-8: Sweden Pap Smear Test Market (Million US$), 2005 2013
Figure 10-9: Sweden Forecast for Pap Smear Test Market (Million US$), 2014 2020
Figure 10-10: Sweden HPV DNA Test Market (Million US$), 2005 2013
Figure 10-11: Sweden Forecast for HPV DNA Test Market (Million US$), 2014 2020
Figure 11-1: Switzerland Cervical Cancer Pap Smear Test Population (Thousand), 2005 2013
Figure 11-2: Switzerland Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014
2020
Figure 11-3: Switzerland Cervical Cancer HPV DNA Test Population (Thousand), 2005 2013
Figure 11-4: Switzerland Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014
2020
Figure 11-5: Switzerland Cervical Cancer Mortality (Number), 2001 2011
Figure 11-6: Switzerland Cervical Cancer Test Market (Million US$), 2005 2013
Figure 11-7: Switzerland Forecast for Cervical Cancer Test Market (Million US$), 2014 2020
Figure 11-8: Switzerland Pap Smear Test Market (Million US$), 2005 2013
Figure 11-9: Switzerland Forecast for Pap Smear Test Market (Million US$), 2014 2020
Figure 11-10: Switzerland HPV DNA Test Market (Million US$), 2005 2013
Figure 11-11: Switzerland Forecast for HPV DNA Test Market (Million US$), 2014 2020
Figure 12-1: Norway Cervical Cancer Pap Smear Test Population (Thousand), 2005 2013
Figure 12-2: Norway Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 2020
Figure 12-3: Norway Cervical Cancer HPV DNA Test Population (Thousand), 2005 2013
Figure 12-4: Norway Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 2020
Figure 12-5: Norway Cervical Cancer Mortality (Number), 2001 2011
Figure 12-6: Norway Cervical Cancer Test Market (Million US$), 2005 2013
Figure 12-7: Norway Forecast for Cervical Cancer Test Market (Million US$), 2014 2020
Figure 12-8: Norway Pap Smear Test Market (Million US$), 2005 2013
Figure 12-9: Norway Forecast for Pap Smear Test Market (Million US$), 2014 2020
Figure 12-10: Norway HPV DNA Test Market (Million US$), 2005 2013
Figure 12-11: Norway Forecast for HPV DNA Test Market (Million US$), 2014 2020
Figure 13-1: Netherlands Cervical Cancer Pap Smear Test Population (Thousand), 2005 2013
Figure 13-2: Netherlands Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014
2020
Figure 13-3: Netherlands Cervical Cancer HPV DNA Test Population (Thousand), 2005 2013
Figure 13-4: Netherlands Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014
2020
Figure 13-5: Netherlands Cervical Cancer Mortality (Number), 2001 2011
Renub Research Page 17 of 24
Figure 13-6: Netherlands Cervical Cancer Test Market (Million US$), 2005 2013
Figure 13-7: Netherlands Forecast for Cervical Cancer Test Market (Million US$), 2014 2020
Figure 13-8: Netherlands Pap Smear Test Market (Million US$), 2005 2013
Figure 13-9: Netherlands Forecast for Pap Smear Test Market (Million US$), 2014 2020
Figure 13-10: Netherlands HPV DNA Test Market (Million US$), 2005 2013
Figure 13-11: Netherlands Forecast for HPV DNA Test Market (Million US$), 2014 2020
Figure 14-1: United States Cervical Cancer Pap Smear Test Population (Thousand), 2005 2013
Figure 14-2: United States Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014
2020
Figure 14-3: United States Cervical Cancer HPV DNA Test Population (Thousand), 2005 2013
Figure 14-4: United States Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014
2020
Figure 14-5: United States Cervical Cancer Mortality (Number), 2001 2011
Figure 14-6: United States Cervical Cancer Test Market (Million US$), 2005 2013
Figure 14-7: United States Forecast for Cervical Cancer Test Market (Million US$), 2014 2020
Figure 14-8: United States Pap smear Test Market (Million US$), 2005 2013
Figure 14-9: United States Forecast for Pap Smear Test Market (Million US$), 2014 2020
Figure 14-10: United States HPV DNA Test Market (Million US$), 2005 2013
Figure 14-11: United States Forecast for HPV DNA Test Market (Million US$), 2014 2020
Figure 15-1: Canada Cervical Cancer Pap Smear Test Population (Thousand), 2005 2013
Figure 15-2: Canada Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 2020
Figure 15-3: Canada Cervical Cancer HPV DNA Test Population (Thousand), 2005 2013
Figure 15-4: Canada Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 2020
Figure 15-5: Canada Cervical Cancer Mortality (Number), 2001 2011
Figure 15-6: Canada Cervical Cancer Test Market (Million US$), 2005 2013
Figure 15-7: Canada Forecast for Cervical Cancer Test Market (Million US$), 2014 2020
Figure 15-8: Canada Pap Smear Test Market (Million US$), 2005 2013
Figure 15-9: Canada Forecast for Pap Smear Test Market (Million US$), 2014 2020
Figure 15-10: Canada HPV DNA Test Market (Million US$), 2005 2013
Figure 15-11: Canada Forecast for HPV DNA Test Market (Million US$), 2014 2020
Figure 16-1: Japan Cervical Cancer Pap Smear Test Population (Thousand), 2005 2013
Figure 16-2: Japan Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 2020
Figure 16-3: Japan Cervical Cancer HPV DNA Test Population (Thousand), 2005 2013
Figure 16-4: Japan Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 2020
Figure 16-5: Japan Cervical Cancer Mortality (Number), 2001 2011
Figure 16-6: Japan Cervical Cancer Test Market (Million US$), 2005 2013
Figure 16-7: Japan Forecast for Cervical Cancer Test Market (Million US$), 2014 2020
Renub Research Page 18 of 24
Figure 16-8: Japan Pap Smear Test Market (Million US$), 2005 2013
Figure 16-9: Japan Forecast for Pap Smear Test Market (Million US$), 2014 2020
Figure 16-10: Japan HPV DNA Test Market (Million US$), 2005 2013
Figure 16-11: Japan Forecast for HPV DNA Test Market (Million US$), 2014 2020
Figure 17-1: Korea Cervical Cancer Pap Smear Test Population (Thousand), 2005 2013
Figure 17-2: Korea Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 2020
Figure 17-3: Korea Cervical Cancer HPV DNA Test Population (Thousand), 2005 2013
Figure 17-4: Korea Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 2020
Figure 17-5: Korea Cervical Cancer Mortality (Number), 2001 2011
Figure 17-6: Korea Cervical Cancer Test Market (Million US$), 2005 2013
Figure 17-7: Korea Forecast for Cervical Cancer Test Market (Million US$), 2014 2020
Figure 17-8: Korea Pap Smear Test Market (Million US$), 2005 2013
Figure 17-9: Korea Forecast for Pap Smear Test Market (Million US$), 2014 2020
Figure 17-10: Korea HPV DNA Test Market (Million US$), 2005 2013
Figure 17-11: Korea Forecast for HPV DNA Test Market (Million US$), 2014 2020
Figure 18-1: Singapore Cervical Cancer Pap Smear Test Population (Thousand), 2005 2013
Figure 18-2: Singapore Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014
2020
Figure 18-3: Singapore Cervical Cancer HPV DNA Test Population (Thousand), 2005 2013
Figure 18-4: Singapore Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014
2020
Figure 18-5: Singapore Cervical Cancer Test Market (Million US$), 2005 2013
Figure 18-6: Singapore Forecast for Cervical Cancer Test Market (Million US$), 2014 2020
Figure 18-7: Singapore Pap Smear Test Market (Million US$), 2005 2013
Figure 18-8: Singapore Forecast for Pap Smear Test Market (Million US$), 2014 2020
Figure 18-9: Singapore HPV DNA Test Market (Million US$), 2005 2013
Figure 18-10: Singapore Forecast for HPV DNA Test Market (Million US$), 2014 2020
Figure 19-1: Malaysia Cervical Cancer Pap Smear Test Population (Thousand), 2005 2013
Figure 19-2: Malaysia Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014
2020
Figure 19-3: Malaysia Cervical Cancer HPV DNA Test Population (Thousand), 2005 2013
Figure 19-4: Malaysia Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 2020
Figure 19-5: Malaysia Cervical Cancer Test Market (Million US$), 2005 2013
Figure 19-6: Malaysia Forecast for Cervical Cancer Test Market (Million US$), 2014 2020
Figure 19-7: Malaysia Pap smear Test Market (Million US$), 2005 2013
Figure 19-8: Malaysia Forecast for Pap smear Test Market (Million US$), 2014 2020
Figure 19-9: Malaysia HPV DNA Test Market (Million US$), 2005 2013
Renub Research Page 19 of 24
Figure 19-10: Malaysia Forecast for HPV DNA Test Market (Million US$), 2014 2020
Figure 20-1: Australia Cervical Cancer Pap Smear Test Population (Thousand), 2005 2013
Figure 20-2: Australia Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014
2020
Figure 20-3: Australia Cervical Cancer HPV DNA Test Population (Thousand), 2005 2013
Figure 20-4: Australia Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 2020
Figure 20-5: Australia Cervical Cancer Mortality (Number), 2001 2011
Figure 20-6: Australia Cervical Cancer Test Market (Million US$), 2005 2013
Figure 20-7: Australia Forecast for Cervical Cancer Test Market (Million US$), 2014 2020
Figure 20-8: Australia Pap Smear Test Market (Million US$), 2005 2013
Figure 20-9: Australia Forecast for Pap Smear Test Market (Million US$), 2014 2020
Figure 20-10: Australia HPV DNA Test Market (Million US$), 2005 2013
Figure 20-11: Australia Forecast for HPV DNA Test Market (Million US$), 2014 2020
Figure 21-1: India Cervical Cancer Pap Smear Test Population (Thousand), 2005 2013
Figure 21-2: India Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 2020
Figure 21-3: India Cervical Cancer HPV DNA Test Population (Thousand), 2005 2013
Figure 21-4: India Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 2020
Figure 21-5: India Cervical Cancer VIA Test Population (Thousand), 2005 2013
Figure 21-6: India Forecast for Cervical Cancer VIA Test Population (Thousand), 2014 2020
Figure 21-7: India Cervical Cancer Test Market (Million US$), 2005 2013
Figure 21-8: India Forecast for Cervical Cancer Test Market (Million US$), 2014 2020
Figure 21-9: India Pap smear Test Market (Million US$), 2005 2013
Figure 21-10: India Forecast for Pap smear Test Market (Million US$), 2014 2020
Figure 21-11: India HPV DNA Test Market (Million US$), 2005 2013
Figure 21-12: India Forecast for HPV DNA Test Market (Million US$), 2014 2020
Figure 21-13: India VIA Test Market (Million US$), 2005 2013
Figure 21-14: India Forecast for VIA Test Market (Million US$), 2014 2020
Figure 22-1: China Cervical Cancer Pap Smear Test Population (Thousand), 2005 2013
Figure 22-2: China Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 2020
Figure 22-3: China Cervical Cancer HPV DNA Test Population (Thousand), 2005 2013
Figure 22-4: China Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 2020
Figure 22-5: China Cervical Cancer VIA Test Population (Thousand), 2005 2013
Figure 22-6: China Forecast for Cervical Cancer VIA Test Population (Thousand), 2014 2020
Figure 22-7: China Cervical Cancer Test Market (Million US$), 2005 2013
Figure 22-8: China Forecast for Cervical Cancer Test Market (Million US$), 2014 2020
Figure 22-9: China Pap smear Test Market (Million US$), 2005 2013
Figure 22-10: China Forecast for Pap Smear Test Market (Million US$), 2014 2020
Renub Research Page 20 of 24
Figure 22-11: China HPV DNA Test Market (Million US$), 2005 2013
Figure 22-12: China Forecast for HPV DNA Test Market (Million US$), 2014 2020
Figure 22-13: China VIA Test Market (Million US$), 2005 2013
Figure 22-14: China Forecast for VIA Test Market (Million US$), 2014 2020
Figure 23-1: Thailand Cervical Cancer Pap Smear Test Population (Thousand), 2005 2013
Figure 23-2: Thailand Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 2020
Figure 23-3: Thailand Cervical Cancer VIA Test Population (Thousand), 2005 2013
Figure 23-4: Thailand Forecast for Cervical Cancer VIA Test Population (Thousand), 2014 2020
Figure 23-5: Thailand Cervical Cancer Test Market (Million US$), 2005 2013
Figure 23-6: Thailand Forecast for Cervical Cancer Test Market (Million US$), 2014 2020
Figure 23-7: Thailand Pap smear Test Market (Million US$), 2005 2013
Figure 23-8: Thailand Forecast for Pap Smear Test Market (Million US$), 2014 2020
Figure 23-9: Thailand VIA Test Market (Million US$), 2005 2013
Figure 23-10: Thailand Forecast for VIA Test Market (Million US$), 2014 2020
Figure 24-1: Indonesia Cervical Cancer Pap Smear Test Population (Thousand), 2005 2013
Figure 24-2: Indonesia Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014
2020
Figure 24-3: Indonesia Cervical Cancer HPV DNA Test Population (Thousand), 2005 2013
Figure 24-4: Indonesia Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 2020
Figure 24-5: Indonesia Cervical Cancer VIA Test Population (Thousand), 2005 2013
Figure 24-6: Indonesia Forecast for Cervical Cancer VIA Test Population (Thousand), 2014 2020
Figure 24-7: Indonesia Cervical Cancer Both (Pap Smear & VIA) Test Population (Thousand), 2005
2013
Figure 24-8: Indonesia Forecast for Cervical Cancer Both (Pap Smear & VIA) Test Population
(Thousand), 2014 2020
Figure 24-9: Indonesia Cervical Cancer Test Market (Million US$), 2005 2013
Figure 24-10: Indonesia Forecast for Cervical Cancer Test Market (Million US$), 2014 2020
Figure 24-11: Indonesia Pap Smear Test Market (Million US$), 2005 2013
Figure 24-12: Indonesia Forecast for Pap Smear Test Market (Million US$), 2014 2020
Figure 24-13: Indonesia HPV DNA Test Market (Million US$), 2005 2013
Figure 24-14: Indonesia Forecast for HPV DNA Test Market (Million US$), 2014 2020
Figure 24-15: Indonesia VIA Test Market (Million US$), 2005 2013
Figure 24-16: Indonesia Forecast for VIA Test Market (Million US$), 2014 2020
Figure 24-17: Indonesia Both (Pap smear & VIA) Test Market (Million US$), 2005 2013
Figure 24-18: Indonesia Forecast for Both (Pap Smear & VIA) Test Market (Million US$), 2014 2020


Renub Research Page 21 of 24
List of Tables:

Table 4-1: Worldwide Cervical Cancer Test Population Share (Percent), 2005 2013
Table 4-2: Worldwide Forecast for Cervical Cancer Test Population Share (Percent), 2014 2020
Table 4-3: Worldwide Cervical Cancer Test Market Share (Percent), 2005 2013
Table 4-4: Worldwide Forecast for Cervical Cancer Test Market Share (Percent), 2014 2020
Table 4-5: Worldwide Cervical Cancer Pap Smear Test Market Share (Percent), 2005 2013
Table 4-6: Worldwide Forecast for Cervical Cancer Pap Smear Test Market Share (Percent), 2014
2020
Table 4-7: Worldwide Cervical Cancer HPV DNA Test Market Share (Percent), 2005 2013
Table 4-8: Worldwide Forecast for Cervical Cancer HPV DNA Test Market Share (Percent), 2014 2020
Table 4-9: Worldwide Cervical Cancer VIA Test Market Share (Percent), 2005 2013
Table 4-10: Worldwide Forecast for Cervical Cancer VIA Test Market Share (Percent), 2014 2020
Table 25-1: Worldwide List of Countries which offer VIA Test via National Programs, 2010
Table 25-2: Worldwide List of Countries which offer VIA Test via Pilot Programs, 2010
Table 25-3: Worldwide Prevalence (Percent) of Young Women (1544 Years) who Have Sex before the
Age of 15 Years, 1994 2006
Table 25-4: Worldwide HPV Prevalence (Percent) among Women with Normal Cervical Cytology, 2010

















Renub Research Page 22 of 24
Order Form

Scan and e-mail this page to info@renub.com, alternatively one can also write the Contact
Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780

Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to
info@renub.com

Format

Report Title: Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA Test &
Patients Worldwide

Single User
(Email from Publisher)
Hard Copy
(Mail Delivery)
CD Rom
(Mail Delivery)
Global Site License
(Multiple User License)
US$ 1,490 US$ 1,790 US$ 1,590 US$ 2,300


For ordering this report: Three easy ways to place your order:

1) Order online by Credit Card (Visa, MasterCard, etc.):
http://www.renub.com/report/cervical-cancer-test-market-patients---pap-smear-hpv-dna-via-
--test-patients---worldwide-131

2) Order by Wire Transfer:
http://www.renub.com/report/wiretransfer.aspx?id=131&pid=1521

To pay by Wire Transfer, please, fill in your contact details in the form below:





Renub Research Page 23 of 24
Bank Details

Account Name: Renub Research
A/C No.: 109102000023296
Name of Bank: IDBI Bank Ltd.
Swift Code: IBKLINBB010
Bank Address: 4
th
Floor
Indian Red Cross Building
1 Red Cross Road
Opposite Parliament Street
New Delhi 110001
India


Contact Information

First Name: Last Name:
Email:
Job Title:
Company:
Address:
City:
Postal/Zip Code:
Country:
Phone:
Mobile:
Fax:
Report Format:
Your message:




Renub Research Page 24 of 24
3) Order by Check

Please post the check accompanied by this form, to:

Company Address: Renub Research
1
st
Floor
C-86, Sector -10
Noida - 201301
Uttar Pradesh
India
Phone: +91-120-421-9822, 424-9780


For free Sample copy report or to view any of our sample work please contact us at
info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA)


Follow Us

Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090
LinkedIn: http://www.linkedin.com/company/renub-research
Twitter: http://twitter.com/RenubResearch